This inventor holds 1 USPTO granted patent. Top assignee: Ligand Pharmaceuticals, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Charlotte L. F. Deckhut: Inventor of Androgen Receptor Modulator Compounds.
Introduction
Charlotte L. F. Deckhut is an inventor associated with San Diego, California, and Ligand Pharmaceuticals, Inc. Her patent work concerns compounds designed to modulate androgen receptors.
Latest Patents
Deckhut is credited with 1 patent: “Tricyclic Quinolinone and Tricyclic Quinoline Androgen Receptor Modulator Compounds and Methods.” The patent describes non-steroidal tricyclic quinolinone and tricyclic quinoline compounds and compositions that can act as androgen receptor agonists, partial agonists, or antagonists. It also covers their preparation and potential uses.
Career Highlights
Deckhut’s listed invention reflects research into non-steroidal compounds that interact with androgen receptors. The patent identifies her work in this area and is associated with Ligand Pharmaceuticals, Inc.
Collaborations
The patent’s listed collaborators include Neelakandha S. Mani and Marquis L. Cummings.
Conclusion
Charlotte L. F. Deckhut’s patent documents her contribution to the development of tricyclic compounds and methods for modulating androgen receptors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile